NouvNeu001
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for NouvNeu001, covering 2024-11-01 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease. [Phase 1]